Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 - June 2020
- PMID: 32996207
- DOI: 10.1111/1471-0528.16266
Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 - June 2020
References
-
- Tham BW, Everard JE, Tidy JA, Drew D, Hancock BW. Gestational trophoblastic disease in the Asian population of Northern England and North Wales. BJOG 2003;110:555-9.
-
- Savage PM, Sita-Lumsden A, Dickson S, Iyer R, Everard J, Coleman R, et al. The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome. J Obstet Gynaecol 2013;33:406-11.
-
- Gockley AA, Melamed A, Joseph NT, Clapp M, Sun SY, Goldstein DP, et al. The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol 2016;140:470-3.
-
- Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010;376:717-29.
-
- Taylor F, Grew T, Everard J, Ellis L, Winter MC, Tidy J, et al. The outcome of patients with low risk gestational trophoblastic disease treated with single agent intramuscular methotrexate and oral folinic acid. Eur J Cancer 2013;49:3184-90.